CS logo
small CS logo
Maine Medical Partners - Women's Health

Scarborough, Maine, United States
Medical group in Scarborough, Maine
100 Campus Dr #125, Scarborough, ME 04074

About Maine Medical Partners - Women's Health


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at Maine Medical Partners - Women's Health


During the past decade, Maine Medical Partners - Women's Health conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "Maine Medical Partners - Women's Health" #1 collaborator was "AstraZeneca" with 1 trials as a collaborator, "Bayer" with 1 trials as a collaborator, "Boehringer Ingelheim" with 1 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator and "Eli Lilly and Company" with 1 trials as a collaborator. Other collaborators include 1 different institutions and companies that were collaborators in the rest 11 trials.

Clinical Trials Conditions at Maine Medical Partners - Women's Health


According to Clinical.Site data, the most researched conditions in "Maine Medical Partners - Women's Health" are "Fallopian Tube Cancer" (2 trials), "Advanced Solid Tumors" (1 trials), "Epithelial Ovarian Cancer" (1 trials), "Lymphoma, Non-Hodgkin" (1 trials) and "Multiple Myeloma" (1 trials). Many other conditions were trialed in "Maine Medical Partners - Women's Health" in a lesser frequency.

Clinical Trials Intervention Types at Maine Medical Partners - Women's Health


Most popular intervention types in "Maine Medical Partners - Women's Health" are "Drug" (3 trials). Other intervention types were less common.
The name of intervention was led by "Abemaciclib" (1 trials), "Atezolizumab and PHESGO" (1 trials), "Atezolizumab and Talazoparib" (1 trials), "Entrectinib" (1 trials) and "Futibatinib" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Maine Medical Partners - Women's Health


The vast majority of trials in "Maine Medical Partners - Women's Health" are 2 trials for "Female" genders and 1 trials for "All" genders.

Clinical Trials Status at Maine Medical Partners - Women's Health


Currently, there are NaN active trials in "Maine Medical Partners - Women's Health". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Maine Medical Partners - Women's Health, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Maine Medical Partners - Women's Health, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".